Utah Code 26B-4-513. Coprescription guidelines
Current as of: 2024 | Check for updates
|
Other versions
(1) As used in this section:
Terms Used In Utah Code 26B-4-513
- Controlled substance: means the same as that term is defined in Title 58, Chapter 37, Utah Controlled Substances Act. See Utah Code 26B-4-501
- Division: means the Division of Professional Licensing created in Section
58-1-103 . See Utah Code 26B-4-501 - Opiate: means the same as that term is defined in Section
58-37-2 . See Utah Code 26B-4-501 - Opiate antagonist: means naloxone hydrochloride or any similarly acting drug that is not a controlled substance and that is approved by the federal Food and Drug Administration for the diagnosis or treatment of an opiate-related drug overdose. See Utah Code 26B-4-501
- Physician: means the same as that term is defined in Section
58-67-102 . See Utah Code 26B-4-501
(1)(a) “Controlled substance prescriber” means the same as that term is defined in Section 58-37-6.5.
(1)(b) “Coprescribe” means to issue a prescription for an opiate antagonist with a prescription for an opiate.
(2) The department shall, in consultation with the Physicians Licensing Board created in Section 58-67-201, the Osteopathic Physician and Surgeon’s Licensing Board created in Section 58-68-201, and the Division of Professional Licensing created in Section 58-1-103, establish by rule, made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, scientifically based guidelines for controlled substance prescribers to coprescribe an opiate antagonist to a patient.